Buying shares in overseas companies can feel complex, particularly when the business isn’t widely recognised in the UK. Zomedica Corp, a US-based veterinary health firm, falls into that category. Specialising in diagnostic tools for companion animals, it has drawn interest from retail investors looking to tap into the growing pet care market.
For UK investors, the practical challenge is accessing a stock listed on an American exchange. The bigger question, however, is whether a niche firm like Zomedica deserves a place in your portfolio.
Here’s a clear look at how to buy Zomedica shares from the UK, which platforms offer access, and what you should weigh up before investing.
In this guide
How to Buy Zomedica Stocks?
How to Buy Zomedica Stocks
Zomedica trades on the NYSE American exchange under the ticker symbol ZOM. As a US-listed stock, it’s not available on the London Stock Exchange; however, UK investors can still purchase it through FCA-regulated brokers that support US markets.
Here’s how to get started:
Not all UK platforms provide access to US markets, so check carefully. Popular options include eToro, Freetrade, and Interactive Brokers. Always confirm the broker is FCA-regulated and review their fees for foreign exchange and international trades.
You’ll need to submit an ID (such as a passport or driving licence) and proof of address. Most platforms also ask basic questions about your investing experience.
You’ll deposit in pounds, but Zomedica trades in US dollars. Brokers usually convert the currency at the point of trade, with typical fees ranging from 0.5% to 1%.
Use the platform’s search function to find Zomedica Corp (ZOM). Please ensure you select the correct listing on the NYSE American exchange.
You can place a market order (buys at the current price) or a limit order (sets your own price). Some brokers offer fractional shares. Note that Zomedica can’t be held in an ISA or SIPP, so any gains may be taxable. You’ll also need to complete a W-8BEN form to reduce US dividend withholding tax from 30% to 15%.
You can place a market order (buys at the current price) or a limit order (sets your own price). Some brokers offer fractional shares. Note that Zomedica can’t be held in an ISA or SIPP, so any gains may be taxable. You’ll also need to complete a W-8BEN form to reduce US dividend withholding tax from 30% to 15%.
Best Brokers to Invest in Zomedica in the UK
If you’re looking to buy Zomedica shares from the UK, choosing the right broker is crucial. Costs, platform features, and user experience can vary widely, and even small fees can eat into returns, especially on lower-priced stocks like Zomedica.
Below are three reliable FCA-regulated brokers that offer access to US markets, including ZOM:
1. eToro
eToro has become one of the most popular platforms for beginners investing in US shares. With a user-friendly interface and commission-free trading on US stocks, it offers a low barrier to entry.
Disclaimer: eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. {etoroCFDrisk}% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Zero commission means that no broker fee will be charged when opening or closing the position and does not apply to short or leveraged positions. Other fees apply including FX fees on non-USD deposits and withdrawals. Your capital is at risk. For more information, click here.
✔Low minimum to fund an account and begin investing
- No commission on US share dealing
- Simple platform that’s ideal for first-time investors
- Offers fractional shares (invest from $10)
- Includes copy trading features for passive learning
- Regulated by the FCA
- A currency conversion fee of 0.5% applies to all USD trades
- No access to ISAs or SIPPs
- Limited research tools compared to traditional brokers
2. CMC Markets Invest
Best known for its CFD offering, CMC Markets also provides a solid share dealing service for those looking to invest in listed stocks like Zomedica. The platform is backed by a long-standing reputation in the UK financial space.
✔ Great selection of assets
- Competitive FX rates and low trading fees
- Access to a wide range of international shares, including the US markets
- FCA-regulated with strong client protection
- Advanced charting and research tools
- No fractional shares, full shares only
- The platform may feel more technical to beginners
- Share dealing and CFD platforms are separate
3. Interactive Brokers (IBKR)
Interactive Brokers is a global heavyweight when it comes to trading infrastructure. While it caters more to experienced traders, its fees and access to global markets are hard to beat.
✔ Top trading platform for advanced
- Incredibly low FX conversion rates (as low as 0.002%)
- Wide access to global stock exchanges, including NYSE American
- Institutional-grade tools and data
- Supports fractional shares in US stocks
- The platform interface can be complex and overwhelming for beginners
- Some account types require a monthly activity minimum
- Not as beginner-friendly as other platforms
Before committing to a platform, take time to compare not just trading commissions but also FX fees, account features, minimum deposits, and the range of tools provided. If you’re planning to invest only a small sum in Zomedica, look for platforms with low currency conversion fees and fractional share access to minimise unnecessary costs.
About Zomedica Corp
Zomedica Corp is a veterinary health company headquartered in Michigan, United States. It focuses on diagnostic and therapeutic technologies for small animal clinics, primarily serving the needs of cats and dogs. Its flagship product, Truforma, is a point-of-care testing platform that allows vets to run diagnostic tests in-clinic, cutting down the wait times and costs associated with sending samples to external labs.
The company operates in a fast-growing segment of the healthcare market. In the US alone, spending on veterinary services has risen steadily as pet owners increasingly prioritise timely, high-quality care for their animals. Zomedica aims to capitalise on this trend by offering fast, reliable diagnostics tailored to the daily needs of vets.
Its business strategy includes expanding the range of tests available on Truforma, acquiring related veterinary businesses, and strengthening its direct relationships with clinics. Despite its ambitions, Zomedica remains a small-cap stock, which means its share price can be highly volatile and more susceptible to speculation.
Zomedica Price Today
Zomedica’s share price has been volatile since gaining traction among retail investors in 2021. As of August 2025, it trades well below its previous highs, with much of its activity driven by sentiment rather than steady financial results.
As a penny stock, priced under $5 with a relatively small market cap, Zomedica is prone to sharp price movements, particularly in response to news, earnings reports, or social media trends. These swings can be sudden and significant, making it a stock that requires close monitoring.
You can view the latest price action and performance using our live Zomedica chart below.
Given the speculative nature of this stock, it’s important to track both its fundamentals and short-term momentum before making any investment decision.
Is Zomedica a Good Investment?
Whether Zomedica is a suitable addition to your portfolio depends on your investment goals and risk tolerance.
Possible Upsides:
- Growing market: The pet care sector continues to expand, with rising demand for in-clinic diagnostic tools.
- Product potential: Truforma offers a practical solution for vets seeking quicker diagnostic results.
- Retail momentum: Its popularity among retail investors can occasionally drive sharp price movements.
Key Risks:
- Volatility: As a penny stock, Zomedica is prone to large swings based on market sentiment or news.
- Lack of profitability: The company has yet to deliver consistent earnings.
- Sector-specific risks: Regulatory changes, R&D setbacks, and competitive pressure remain ongoing challenges.
For UK investors, currency risk is another factor. Since Zomedica is priced in US dollars, any appreciation of the pound can reduce returns when profits are converted back to sterling.
Zomedica may appeal to investors looking for speculative, high-risk opportunities within a diversified portfolio. However, it is unlikely to serve as a long-term core holding alongside more stable assets like FTSE 100 shares or global ETFs. Caution is advised; only invest what you can afford to lose.
FAQs
No, but you’ll need a broking account that supports US stock trading. Make sure the platform is FCA-regulated and allows trading in US dollars.
Not in most cases. Because Zomedica trades on the NYSE American exchange, it doesn’t meet HMRC’s criteria for ISA or SIPP inclusion. Any gains would be subject to Capital Gains Tax.
Penny stocks tend to be volatile and can rise or fall quickly on speculation or market chatter. Prices often react to headlines or social media rather than company fundamentals, so careful risk management is essential.
Its low share price and exposure to a growing sector make it appealing to investors looking for speculative upside. Online discussion forums have also contributed to occasional spikes in interest and volume.
Conclusion
For UK investors considering Zomedica, the key is recognising what kind of investment it is. While the company operates in a growing sector and offers potential upside, its prospects remain speculative. This isn’t a stock for chasing quick wins – it’s one that belongs, if at all, in the high-risk corner of a well-balanced portfolio.
If you’re interested in the pet healthcare space, Zomedica could play a small role in a broader strategy. Just approach it with clear expectations, solid risk management, and a long-term view grounded in fundamentals rather than hype.
Related Articles:
25,000 hours of testing 60+ brokers. Our recommended broker is Capital.com.
Our recommended broker is Capital.com.
